DBV Technologies S.A. (DBVT) Financials

DBVT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 183.0 million 42.8 million
2023-09-30 189.8 million 45.8 million
2023-06-30 217.5 million 53.3 million
2023-03-31 232.9 million 53.8 million

DBVT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -14.0 million 1.2 million
2023-09-30 -19.6 million 1.4 million
2023-06-30 -25.7 million 1.8 million
2023-03-31 -21.0 million 1.6 million

DBVT Net Income

No data available :(

DBVT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 141.4 million - 5.7 million
2023-09-30 149.1 million - 1.6 million
2023-06-30 174.0 million - 2.1 million
2023-03-31 192.3 million - 2.6 million

DBVT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 192.4 million
2023-09-30 96.1 million
2023-06-30 94.3 million
2023-03-31 94.0 million

DBVT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 352000 28.0 million 6.4 million 101000
2023-09-30 50000 13.8 million 6.2 million 700000
2023-06-30 164000 17.6 million 7.0 million 516000
2023-03-31 111000 16.0 million 5.2 million 434000

DBVT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -13.6 million
2023-09-30 2.4 million 455635
2023-06-30 2.3 million 5.0 million
2023-03-31 2.2 million 3.6 million

DBVT

Price: $0.67

52 week price:
0.65
2.37

Earnings Per Share: -0.38 USD

P/E Ratio: -1.56

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 78800

Ebitda: -157.7 million

Market Capitalization: 138.5 million

Links: